History, Power, and the Peril of Governing by Spectacle

The controversy surrounding President Trump’s attempted National Guard deployments to major U.S. cities is not merely a skirmish over public safety policy. It is a revealing moment about how power is exercised, justified, and constrained in a constitutional republic, and about what happens when political theater collides with historical and legal reality. At its core,…

Whose Guard Is It Anyway?

When armored trucks and camo uniforms roll down city streets, it’s hard not to feel a twinge of unease, even for those of us who appreciate law and order. Over the past few months, National Guard convoys have appeared in a few urban battlegrounds, all under orders from Washington. Governors are suing, federal lawyers are…

The Court, the Constitution, and Trump’s Los Angeles Deployment

The summer of 2025 was already simmering when Los Angeles became the epicenter of a political and constitutional storm. After a series of high-profile immigration raids swept through Southern California, the streets filled with demonstrators. Some were peaceful, gathering in large numbers to voice opposition to federal policy. Others grew heated, with scuffles breaking out…

In Defense of Order or an Overstep? President Trump’s Deployment of Troops to Los Angeles

In a bold and highly controversial move, President Trump took swift action to restore order in Los Angeles, where anti-deportation protests had spiraled into widespread unrest. On June 8, he ordered the deployment of the National Guard without the consent of California’s governor. Roughly 500 active-duty Marines were dispatched the next day to safeguard federal…

Mifepristone, State Sovereignty, and the Battle for Life: Why the States Must Have the Right to Sue

In the ever-escalating cultural and constitutional war over abortion in America, the fight over mifepristone—the so-called “abortion pill”—has emerged as ground zero. Recently, Idaho, Kansas, and Missouri filed a lawsuit challenging the FDA’s loosened restrictions on mifepristone, arguing that federal approval and telehealth access undermine their pro-life laws. President Trump’s Department of Justice is asking…